Stay updated on Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial
Sign up to get notified when there's something new on the Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial page.

Latest updates to the Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial page
- Check4 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check10 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1, while the page continued to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal header and a Home link, indicating the record is inaccessible; the prior sponsor and study content appears to have been removed from the page.SummaryDifference17%

- Check32 days agoChange DetectedThe page shows an updated revision tag, indicating a version update of the page rendering or documentation rather than changes to the study data. This is a platform-level update and does not modify the study details.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision badge updated from v3.6.5 to v3.6.6, indicating a minor metadata update rather than a substantive change. No user-facing content or functionality was altered.SummaryDifference0.0%

- Check52 days agoChange DetectedA new entry '2015 ( U.S. NIH Grant/Contract )' was added to the study identifiers, reflecting an additional NIH funding/identifier reference for the study.SummaryDifference0.0%

Stay in the know with updates to Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial page.